Emergency Department Visit clinical trials

Explore recruiting emergency department visit clinical trials.

Recruiting emergency department visit studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Emergency Department Visit trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Multi-center, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of self-administered subcutaneous selatogrel for prevention of all-cause death and treatment of acute myocardial infarction in subjects with a recent history of acute myocardial infarction

Austria, Netherlands, Denmark, Poland, Romania, Slovakia +17 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose Ranging Study to Assess the Efficacy and Safety of Rocatinlimab in Adult Subjects With Moderate-to-severe Asthma

Romania, Czechia, Hungary, Poland, Bulgaria

Therapeutic exploratory (Phase II) EU CTIS Study details

A Multicenter, Randomized, Double-blind, Chronic-dosing, Parallel-group, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab 100 mg in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with a History of Frequent COPD Exacerbations and Elevated Peripheral Blood Eosinophils (RESOLUTE)

Netherlands, Spain, Sweden, Denmark, Italy, Hungary +7 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase 2, Multicenter, Randomized, Parallel, 3-arm, Placebo-controlled Study to Assess Efficacy and Safety of CDR132L in Patients with Reduced Left Ventricular Ejection Fraction (≤ 45%) After Myocardial Infarction (HF-REVERT)

Poland, Spain, Czechia, Greece, Netherlands, Germany +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

C4531031 - AN INTERVENTIONAL PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, THIRD PARTY-UNBLINDED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO INVESTIGATE EFFICACY AND SAFETY OF PF-07275315 IN ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

Spain, Germany, Poland, Czechia, Greece, Italy +3 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Oral Prednisolone for Acute Rhinovirus Induced Wheezing in Children Less Than 2 Years of Age: RhinoPOC RCT

Finland

Therapeutic use (Phase IV) EU CTIS Study details

Emergency Department Visit trials by city

Emergency Department Visit in Toronto Emergency Department Visit in Vancouver Emergency Department Visit in Montreal Emergency Department Visit in Calgary Emergency Department Visit in Edmonton Emergency Department Visit in Ottawa Emergency Department Visit in Winnipeg Emergency Department Visit in Quebec City Emergency Department Visit in Hamilton Emergency Department Visit in Kitchener Emergency Department Visit in London Emergency Department Visit in Halifax Emergency Department Visit in New York Emergency Department Visit in Los Angeles Emergency Department Visit in Chicago Emergency Department Visit in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease